June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Prevalence of Glaucoma by Race/Ethnicity in the California Medicare Population
Author Affiliations & Notes
  • Victoria Tseng
    Ophthalmology, University of California Los Angeles, Los Angeles, California, United States
  • Ken Kitayama
    Ophthalmology, University of California Los Angeles, Los Angeles, California, United States
    Epidemiology, University of California Los Angeles, Los Angeles, California, United States
  • Fei Yu
    Ophthalmology, University of California Los Angeles, Los Angeles, California, United States
    Biostatistics, University of California Los Angeles, Los Angeles, California, United States
  • Anne L. Coleman
    Ophthalmology, University of California Los Angeles, Los Angeles, California, United States
    Epidemiology, University of California Los Angeles, Los Angeles, California, United States
  • Footnotes
    Commercial Relationships   Victoria Tseng None; Ken Kitayama None; Fei Yu None; Anne Coleman None
  • Footnotes
    Support  Unrestricted grant from Resarch to Prevent Blindness to UCLA Department of Ophthalmology
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 1635 – A0130. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Victoria Tseng, Ken Kitayama, Fei Yu, Anne L. Coleman; Prevalence of Glaucoma by Race/Ethnicity in the California Medicare Population. Invest. Ophthalmol. Vis. Sci. 2022;63(7):1635 – A0130.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To examine the prevalence of glaucoma by race/ethnicity in the 2019 California (CA) Medicare population.

Methods : The study population included all 2019 CA Medicare beneficiaries ≥65 years old who had both Part A and Part B coverage. Race/ethnicity was obtained from the Medicare enhanced race/ethnicity code and was categorized into White, Black, Asian, Hispanic, and Other/Unknown. Glaucoma was defined by diagnosis codes and included any glaucoma, primary open angle glaucoma (POAG), secondary open angle glaucoma (SOAG), and angle closure glaucoma (ACG). Covariates included age, sex, Charlson Comorbidity Index, pseudophakia, and macular degeneration. Univariable comparisons of glaucoma prevalence by race/ethnicity was performed using chi-squared tests. Multivariable analyses were performed using logistic regression, while adjusting for all covariates.

Results : The study population included 5,856,492 CA Medicare beneficiaries, of whom 3,340,658 (57.0%) were White, 317,631 (5.4%) were Black, 760,673 (13.0%) were Asian, 1,203,503 (20.6%) were Hispanic, and 234,027 (4.0%) were Other/Unknown. There were 220,662 (3.8%) beneficiaries with any glaucoma, 171,988 (2.9%) with POAG, 8,827 (0.2%) with SOAG, and 12,978 (0.2%) with ACG. Compared to White beneficiaries, Black, Asian, Hispanic, and Other/Unknown beneficiaries had increased adjusted odds of any glaucoma (Black odds ratio [OR]=1.70, 95% confidence interval [CI]=1.67, 1.73; Asian OR=1.60, 95% CI=1.58, 1.62; Hispanic OR=1.05, 95% CI=1.04, 1.07; Other/Unknown OR=1.30, 95% CI=1.27, 1.33), POAG (Black OR=1.79, 95% CI=1.75, 1.83; Asian OR=1.40, 95% CI=1.38, 1.42; Hispanic OR=1.07, 95% CI=1.06, 1.09; Other/Unknown OR=1.26, 95% CI=1.23, 1.30), and ACG (Black OR=2.18, 95% CI=2.02, 2.37; Asian OR=5.09, 95% CI=4.89, 5.30; Hispanic OR=1.69, 95% CI=1.60, 1.78; Other/Unknown OR=2.05, 95% CI=1.88, 2.24) but lower adjusted odds of SOAG for most race/ethnicities (Black OR=0.30, 95% CI=0.25, 0.35; Asian OR=0.47, 95% CI=0.44, 0.51; Hispanic OR=0.47, 95% CI=0.44, 0.51; Other/Unknown OR=1.17, 95% CI=1.06, 1.29).

Conclusions : In the 2019 CA Medicare population, there were racial/ethnic differences in the prevalence of glaucoma with higher odds in Black and Asian relative to Hispanic and White populations, which is different from prior population-based studies. Further investigation is required to determine the etiology of these differences.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×